Edge Medical Robotics
Focused on design, development, and commercialization of the most advanced medical devices around the world.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor | €0.0 | round | |
* | $200m | Series C | |
| Total Funding | 000k | ||
Related Content
Edge Medical Robotics, established in Shenzhen in 2017, is a firm focused on the development and commercialization of surgical robots for minimally invasive procedures. The company was co-founded by Dr. Wang Jianchen, who holds a joint Ph.D. from Tianjin University and MIT, and another doctoral graduate from Harvard University. Dr. Wang's leadership has been central to industrializing high-end surgical robotics in China and securing over 2 billion yuan in financing from notable investors like Sequoia Capital, Temasek, and Boyu Capital.
The company targets the rapidly expanding surgical robot market in China, a sector historically dominated by foreign systems like the Da Vinci robot and characterized by low penetration compared to the U.S. Edge Medical's business model involves selling robotic systems—hardware and software—to hospitals, supplemented by recurring revenue from maintenance and supporting hardware. This strategy addresses a significant unmet clinical need in a country with a high volume of surgical operations.
Edge Medical has developed a portfolio of products, making it the second company globally to master multi-port, single-port, and bronchoscopic robotic technologies. Its main offerings include the MP1000 multi-port system and the SP1000 single-port system. The MP1000, which has received registration approval from China's NMPA, is a four-arm robot with a 3D high-definition endoscope designed for urology, gynecology, general, and thoracic surgery. The SP1000 is engineered to be less invasive by requiring only a single incision, which can reduce patient trauma and recovery time. The company also offers the Edge Cloud® Remote Surgery System, which enabled a transcontinental tele-surgery in 2024. As of early 2024, the MP1000 has been used in over 1,500 clinical procedures across China.
Keywords: surgical robotics, minimally invasive surgery, laparoscopic robots, medical devices, single-port surgery, multi-port surgery, medtech, healthcare technology, surgical systems, tele-surgery